Triple reuptake inhibitors (TRIs): do they promise us a rose garden?
نویسندگان
چکیده
منابع مشابه
Triple Reuptake Inhibitors: A Premise and Promise
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have a role in treating depressive disorders, and it is plausible they may have potential efficacy in obesity, addiction, and pain syndromes. The curren...
متن کاملMonoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
Over 75% of depressed patients suffer from painful symptoms predicting a greater severity and a less favorable outcome of depression. Imaging, anatomical and functional studies have demonstrated the existence of common brain structures, neuronal pathways and neurotransmitters in depression and pain. In particular, the ascending serotonergic and noradrenergic pathways originating from the raphe ...
متن کاملDo they mean us?
Throughout Britain, nurse teachers and higher education staff are learning more about each other as the incorporation of colleges of nursing and midwifery (and colleges of health) into higher education gathers momentum. The Times Higher Education Supplement, now simply The Higher has been part of my weekly reading for the past ten years, as befits a career which combines nursing and higher educ...
متن کاملSerotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
The precise mechanisms of pain perception and transmission in the central nervous system have not been fully elucidated. However, extensive data support a role for the monoamine neurotransmitters, serotonin and norepinephrine, in the modulation of pain. Experiments with animal models of pain indicate that noradrenergic interventions, and to a lesser extent serotonergic interventions, reduce pai...
متن کاملDo selective serotonin reuptake inhibitors cause suicide?
Editor—Gunnell et al’s report on suicide risk with selective serotonin reuptake inhibitors (SSRIs) raises several issues. Firstly, clinicians have observed that the first weeks of treatment of severe depression with an antidepressant are accompanied by a higher risk of suicide because of a drug induced motor disinhibition that is not yet accompanied by mood improvement. Secondly, the authors’ f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Psychiatry and Clinical Psychopharmacology
سال: 2018
ISSN: 2475-0573,2475-0581
DOI: 10.1080/24750573.2018.1443386